The Onco Life Podcast
In this episode, we explore how targeted therapy drugs are changing the way liver cancer is treated, offering more precise treatment options for patients with advanced disease. You’ll learn: • What targeted therapy is and how it works against liver cancer cells • How targeted drugs help slow tumor growth and block cancer growth signals • The difference between tyrosine kinase inhibitors and monoclonal antibodies • When targeted therapy may be recommended for hepatocellular carcinoma (HCC) and primary liver cancer • How these treatments can help when surgery or a liver transplant is not possible • Common side effects, including fatigue, skin changes, and high blood pressure • The role of clinical trials in developing new targeted therapies • How targeted therapy may be combined with other liver cancer treatments for better outcomes Whether you are a patient, caregiver, or simply looking to understand modern liver cancer treatment options, this episode provides a clear overview of how targeted therapies help control disease progression and improve quality of life. Blog Link: Targeted Therapy Drugs for Liver Cancer: A Complete Guide [https://oncolifecentre.com/targeted-therapy-drugs-for-liver-cancer-a-complete-guide] Send us Fan Mail [https://www.buzzsprout.com/2471969/fan_mail/new] Thank you for listening to The Onco Life Podcast, your trusted source for expert cancer information and patient-centered education. Author: Dr. CHRISTINA NG VAN TZE [https://oncolifecentre.com/author/dr-christina-ng-van-tze/] 📍 Visit us at oncolifecentre.com [https://oncolifecentre.com] 📞 Call: +603-2242-2620 📧 Book a consultation or ask a question — we're here to support your journey.
226 episodes
Comments
0Be the first to comment
Sign up now and become a member of the The Onco Life Podcast community!